comparemela.com

Neal Shore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pluvicto May Slow Progression Earlier in Advanced Prostate Cancer

Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR.

United statesDana farber cancer instituteXiaox weiDrug administrationAmerican urological association annual meetingCarolina urologic research centerNeal shore

Erleada, ADT One-Two Punch in Prostate Cancer Treatment

The postsurgical combination of androgen deprivation therapy and Erleada has shown promising results in prostate cancer.

United statesCarolina urologic research centerNational cancer instituteAmerican urological association annual meetingDrug administrationNational cancerUrological association annual meetingNeal shoreCarolina urologic research

J&J: encouraging results in prostate cancer

Johnson & Johnson has announced results from an open-label Phase 2 study evaluating adjuvant treatment with Erleada and androgen deprivation therapy in patients with HRLPC who have undergone.

Neal shoreChief medical officerSurgical oncology

Dr Shore on the Importance of a Multidisciplinary Team in Urologic Oncology

Neal Shore, MD, FACS, discusses the importance of a multidisciplinary team in light of recent developments in urologic oncology.

Carolina urologic research centerNeal shoreMedical officerGenesiscare united statesAtlantic urology clinicsBacillus calmetteUrothelial cancerMultidisciplinary careEnfortumab vedotin ejfv padcevCheckmate 901V 302 keynote a39 nct04223856

Dr Shore on Key Clinical Trial Data in Biochemically Recurrent Prostate Cancer

Neal Shore, MD, FACS, discusses findings from clinical trials in patients with prostate cancer who experience biochemical recurrence.

Carolina urologic research centerNeal shoreMedical officerGenesiscare united statesAtlantic urologyBiochemical recurrenceProstate cancerPhase 3 embark trial nct02319837

vimarsana © 2020. All Rights Reserved.